V-CREATE research recognized at AHA Scientific Sessions 2018
November 13, 2018
V-CREATE researcher, Meredith Duncan, was recognized at the 2018 AHA Scientific Sessions with the Paul Dudley White International Scholar Award for the highest rated abstract from the United States. Duncan's abstract utilized Framingham Heart Study data to examine the impact of quitting smoking relative to cardiovascular disease (CVD) risk. Prior evidence supports rapid elimination of excess risk within a few year since quitting, but these data were simulated or derived using cohorts with few assessments of smoking status during follow-up.
V-CREATE grant bolsters peripheral artery disease research
November 13, 2018
http://news.vumc.org/2018/01/18/grant-bolsters-peripheral-artery-disease-research/
Vanderbilt University Medical Center (VUMC) recently secured its third American Heart Association (AHA) Strategically Focused Research Network (SFRN) award to address the challenges of limb problems in peripheral artery disease (PAD).
The four-year, $3.7 million grant will provide funding for the Medical Center’s project “Microvascular Disease Determines Limb Outcomes in PAD.”
New HIV research training program launched
September 25, 2018
http://news.vumc.org/2018/09/20/new-hiv-research-training/
A new HIV research training program launched as a joint effort by V-CREATE director, Dr. Matthew Freiberg and Dr. John Koethe of the Department of infectious Diseases called Vanderbilt Scholars in HIV and Heart, Lung, Blood and Sleep Research, or V-SCHoLARs will focus on heart, lung, blood and sleep (HLBS) disorders in people living with HIV/AIDS. The new training program was recently featured in the VUMC Reporter.
V-CREATE Featured in Washington Post and PHA
May 4, 2018
The work of our investigators have recently been featured by the Washington Post and the Pulmonary Hypertension Association.
Dr. Brittain's study on HIV and pulmonary hypertension in the Veterans Aging Cohort Study was featured by the Pulmonary Hypertension Association.
Drs. Tindle & Wells Personalized Smoking Study Featured
November 27, 2017
Center investigators, Dr. Hilary Tindle and Dr. Quinn Wells, have been working on personalizing tobacco cessation treatment. Current smokers interested in quitting can get tested for the speed of nicotine metabolism ("normal" or "slow"), which may help in pharmaceutical tailoring. This work has been featured on research news @ Vanderbilt.
Nashville VACS Site Up & Running
November 17, 2017
The Tennessee Valley Healthcare System in Nashville is the newest site of the Veterans Aging Cohort Study (VACS). The Veterans Aging Cohort Study (VACS) is a prospective, observational cohort study of HIV- positive and an age/race/site matched control group of HIV- negative veterans in care in the United States.
More information about the overall study can be found on Yale's VACS website.
HIV and Heart Failure Work Featured
May 1, 2017
V-CREATE and VACS's work looking at individuals with HIV infection and their heart failure outcomes was recently featured in research news @ Vanderbilt. This is the first large study to reveal a higher risk of heart failure with reduced and preserved ejection fraction in HIV-infected individuals. The research news article highlights Dr.
Dr. Freiberg Featured on URBAN ARCH Spotlight Series
October 6, 2016
If you are interested in getting to know V-CREATE Director Dr. Freiberg, take a look at the Uganda Russia Boston Alcohol Network for Alcohol Research Collabroation on HIV/AIDS (URBAN ARCH) Spotlight.
Congratulations, Dr. Chang!
September 26, 2016
Collaborator Dr. Joyce Chang, PhD, received the honor of Statistician of the Year by Pittsburgh Chapter of the American Statistical Association.